Chemical activators of RWDD2A can engage multiple cellular signaling pathways to elicit functional activation of the protein. Phorbol 12-myristate 13-acetate, commonly known as PMA, directly activates protein kinase C (PKC), which in turn can phosphorylate RWDD2A, leading to its functional enhancement. This activation process is a classic example of signal transduction involving PKC, which plays a pivotal role in various cellular processes. Similarly, Forskolin raises intracellular cAMP levels, thereby activating protein kinase A (PKA). The activation of PKA can result in the phosphorylation of RWDD2A or its associated proteins, thus promoting RWDD2A's activity. Ionomycin, as another example, increases intracellular calcium concentrations, subsequently activating calmodulin-dependent kinases that can also target RWDD2A for phosphorylation. This phosphorylation serves as a regulatory mechanism, changing the functional state of the protein.
Another cAMP analog, 8-Bromo-cAMP, emulates the action of Forskolin by activating PKA, with the same potential for RWDD2A activation through phosphorylation. Okadaic Acid and Calyculin A, both inhibitors of protein phosphatases, lead to the accumulation of phosphorylated proteins, including RWDD2A, therefore activating it. Anisomycin triggers the MAP kinase pathway, which can result in the activation of RWDD2A through the action of MAP kinases. Thapsigargin, by inducing endoplasmic reticulum stress, may activate RWDD2A through the unfolded protein response, a complex network of signaling pathways aiming to restore normal cell function. Bisindolylmaleimide I, although a PKC inhibitor, can at low concentrations activate PKC, leading to downstream phosphorylation and activation of RWDD2A. Dibutyryl-cAMP, another cAMP analog, activates PKA, which might directly phosphorylate RWDD2A, thus promoting its activation. Lithium Chloride, by inhibiting GSK-3, can lead to the activation of RWDD2A by preventing inhibitory phosphorylation. Lastly, Staurosporine, a well-known PKC activator, can facilitate the phosphorylation and subsequent activation of RWDD2A, adding to the repertoire of chemical activators that utilize phosphorylation as a means to modulate RWDD2A activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Direct activator of protein kinase C (PKC) which can phosphorylate RWDD2A leading to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, indirectly activating calmodulin-dependent kinases which could phosphorylate and activate RWDD2A. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that activates PKA, leading to potential phosphorylation of RWDD2A, resulting in its activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation and thus activation of proteins including RWDD2A. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibits protein phosphatases, leading to the activation of RWDD2A through increased phosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates the MAP kinase pathway, which could lead to the activation of RWDD2A through phosphorylation by MAP kinases. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Induces ER stress leading to the activation of the unfolded protein response which may activate RWDD2A through adaptive cellular signaling pathways. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Specific PKC inhibitor that at low concentrations can paradoxically activate PKC, resulting in downstream activation of RWDD2A through phosphorylation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that activates PKA; PKA then can phosphorylate and activate RWDD2A. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits glycogen synthase kinase-3 (GSK-3), potentially leading to activation of RWDD2A through reduced inhibitory phosphorylation. | ||||||